390 related articles for article (PubMed ID: 23539444)
1. Collagen prolyl hydroxylases are essential for breast cancer metastasis.
Gilkes DM; Chaturvedi P; Bajpai S; Wong CC; Wei H; Pitcairn S; Hubbi ME; Wirtz D; Semenza GL
Cancer Res; 2013 Jun; 73(11):3285-96. PubMed ID: 23539444
[TBL] [Abstract][Full Text] [Related]
2. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
[TBL] [Abstract][Full Text] [Related]
3. Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis.
Gilkes DM; Bajpai S; Wong CC; Chaturvedi P; Hubbi ME; Wirtz D; Semenza GL
Mol Cancer Res; 2013 May; 11(5):456-66. PubMed ID: 23378577
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts.
Gilkes DM; Bajpai S; Chaturvedi P; Wirtz D; Semenza GL
J Biol Chem; 2013 Apr; 288(15):10819-29. PubMed ID: 23423382
[TBL] [Abstract][Full Text] [Related]
5. Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance.
Xiong G; Stewart RL; Chen J; Gao T; Scott TL; Samayoa LM; O'Connor K; Lane AN; Xu R
Nat Commun; 2018 Oct; 9(1):4456. PubMed ID: 30367042
[TBL] [Abstract][Full Text] [Related]
6. Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels.
Grimmer C; Balbus N; Lang U; Aigner T; Cramer T; Müller L; Swoboda B; Pfander D
Am J Pathol; 2006 Aug; 169(2):491-502. PubMed ID: 16877351
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes.
Aro E; Khatri R; Gerard-O'Riley R; Mangiavini L; Myllyharju J; Schipani E
J Biol Chem; 2012 Oct; 287(44):37134-44. PubMed ID: 22930750
[TBL] [Abstract][Full Text] [Related]
8. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
Yang W; Wu X; Zhou F
Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
10. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.
Wang T; Gilkes DM; Takano N; Xiang L; Luo W; Bishop CJ; Chaturvedi P; Green JJ; Semenza GL
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3234-42. PubMed ID: 24938788
[TBL] [Abstract][Full Text] [Related]
12. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
[TBL] [Abstract][Full Text] [Related]
13. Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.
Aprelikova O; Pandolfi S; Tackett S; Ferreira M; Salnikow K; Ward Y; Risinger JI; Barrett JC; Niederhuber J
Cancer Res; 2009 Jan; 69(2):616-24. PubMed ID: 19147576
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures by ethyl 3,4-dihydroxybenzoate.
Majamaa K; Sasaki T; Uitto J
J Invest Dermatol; 1987 Oct; 89(4):405-9. PubMed ID: 2822818
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells.
Takahashi Y; Takahashi S; Shiga Y; Yoshimi T; Miura T
J Biol Chem; 2000 May; 275(19):14139-46. PubMed ID: 10799490
[TBL] [Abstract][Full Text] [Related]
16. Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action.
Sasaki T; Majamaa K; Uitto J
J Biol Chem; 1987 Jul; 262(19):9397-403. PubMed ID: 3036858
[TBL] [Abstract][Full Text] [Related]
17. Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.
Bordoli MR; Stiehl DP; Borsig L; Kristiansen G; Hausladen S; Schraml P; Wenger RH; Camenisch G
Oncogene; 2011 Feb; 30(5):548-60. PubMed ID: 20856199
[TBL] [Abstract][Full Text] [Related]
18. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxia attenuates the inhibitory effect of nitric oxide donors on HIF prolyl-4-hydroxylase-2: Implication on discriminative effect of nitric oxide on HIF prolyl-4-hydroxylase-2 and collagen prolyl-4-hydroxylase.
Yum S; Choi J; Hong S; Park MH; Lee J; Ha NC; Jung Y
Biochem Pharmacol; 2011 Sep; 82(5):485-90. PubMed ID: 21723853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
